Dual Treatment Drugs Have Increased Life Of Men With Metastatic Prostate Cancer By 6 Months
Since the introduction of ‘dual treatment’ drugs, survival rates for men with metastatic prostate cancer have increased by an average of six months, according to National Prostate Cancer Register…